India GDP is expected to expand by 7.4% in FY 2025-26, backed by strong investment and growth led by the services and ...

《2025年财政法》修订了《1961年所得税法》第92CA条，新增“重复交易”机制。根据该框架，纳税人可选择将某一年度确定的独立交易价格（ALP），适用于其后连续两个年度内的“类似”国际交易或特定国内交易。该规定自2026年4月1日起生效，适用于20 ...

Indian Railways has operationalized over 90 percent of its Dedicated Freight Corridor (DFC), covering a distance of over 2,800 kilometers. Utilizing the advantages of this freight-focused ...

India’s thriving chemical industry owes its success to escalating demand and supportive government policies. India’s chemical sector is ranked the sixth-largest globally by output and third in Asia.

A revised Occupational Safety, Health, and Working Conditions (OSH) Code enacted in September 2020 replaced its 2019 version. It applies to workers engaged in factories, mines, plantations, motor ...

India’s manufacturing sector has witnessed major new investments in production facilities by leading multinational corporations like Siemens, GE, Philips, Samsung Electronics, PepsiCo, ABB, Micron, ...

India is rapidly emerging as a global hub for Global Capability Centers (GCCs), specialized operational hubs established by multinational corporations to centralize and optimize business processes.

The 18th G20 Summit of 2023 recently concluded in New Delhi, India, marking the first-ever G20 summit hosted by the country. The summit’s theme, “Vasudhaiva Kutumbakam” or “One Earth, One Family, One ...

In 2025, India emerged as one of the leading global markets for hiring intent, supported by expansion strategies, digital transformation, and strong demand across energy, finance, IT, and ...

New York (US$14.1 billion) and New Jersey (US$10.1 billion) serve as primary gateways for Indian gems, jewelry, and pharmaceuticals. California (US$7.6 billion) and Texas (US$7.4 billion) are major ...

India is considering a major legislative reform that could transform the country’s immigration framework. On March 11, 2025, the central government introduced the Immigration and Foreigners Bill, 2025 ...

In a striking new milestone, Eli Lilly’s weight-loss therapy Mounjaro (tirzepatide) became India’s top-selling drug by value in October 2025, overtaking GSK’s antibiotic Augmentin, according to ...